Mariel Pietri

Title: Mariel Pietri: Innovator in Peptide Research

Introduction

Mariel Pietri is a notable inventor based in Ajaccio, France. She has made significant contributions to the field of peptide research, particularly in the context of treating depression. Her innovative work has led to the development of new therapeutic options that could benefit many individuals suffering from this condition.

Latest Patents

Mariel Pietri holds a patent for "Peptides derived from the propeptide NTSR3 and their use in the treatment of depression." This patent discloses new peptides derived from the neurotensin receptor 3 (NTSR3) and outlines their potential applications in treating various diseases, with a particular focus on depression. She has 1 patent to her name, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Mariel has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université de Nice Sophia Antipolis. These experiences have allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Mariel has collaborated with notable colleagues, including Jean Mazella and Marc Borsotto. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Mariel Pietri's innovative research in peptide development represents a significant advancement in the treatment of depression. Her contributions to science and collaboration with esteemed institutions and colleagues highlight her dedication to improving mental health therapies.